Sageworth Trust CO Of South Dakota Catalent, Inc. Transaction History

Sageworth Trust CO Of South Dakota

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$72.36 - $113.1 $6,440 - $10,065	-89 Reduced 78.07%	25 $2,000
Q2 2022 Jul 28, 2022	BUY	$87.2 - $114.05 $2,180 - $2,851	25 Added 28.09%	114 $12,000
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $38,146 - $50,418	-405 Reduced 81.98%	89 $10,000
Q4 2021 Feb 10, 2022	BUY	$119.57 - $139.07 $59,067 - $68,700	494 New	494 $63,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO Of South Dakota, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO Of South Dakota with notifications on news.